Re: The crick didn’t rise, here’s the presentation, finally!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10553 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: The crick didn’t rise, here’s the presentation, finally!

in response to

Re: The crick didn’t rise, here’s the presentation, finally!

jonzobot

posted on Oct 28, 2023 04:13PM

jonsobot: "Well, TNBC has been abandoned as we all know."

Slide 3 of the AGM Presentation shows 2 TNBC studies that are ongoing. What am I missing?